AbbVie Partner Spotlight

Featured

Sponsored by AbbVie Medical Affairs
Sponsored by AbbVie Medical Affairs
03/11/2022
Treatment goals can be challenging for those with RA who are bDMARD-IR. Hear Dr. Tesser’s approach and learn about SELECT-BEYOND, where a JAK inhibitor was assessed in such patients.
03/11/2022
Sponsored by AbbVie Medical Affairs
Sponsored by AbbVie Medical Affairs
05/04/2022
Many patients with PsA cannot achieve comprehensive control of their symptoms, despite a variety of available treatments. Learn more about an available JAK inhibitor along with findings from the two phase 3...
05/04/2022